• SENSEX 81,451.01
    -182.01 (--0.22%)
  • BANKNIFTY 55,749.70
    203.65 (+0.37%)
  • Suzlon Energy
    74.30 86.04(%)
  • Reliance Power
    60.50 60.50(%)
  • Swiggy
    338.00 617.00(%)
  • Mazagon Dock
    3,450.00 1,200.00(%)
  • Eternal Ltd
    243.00 304.50(%)
  • MMTC
    88.20 131.88(%)
  • Garden Reach Sh.
    2,926.85 1,148.10(%)
  • Waaree Energies
    2,956.60 1,808.65(%)
  • Indian Energy Ex
    203.20 244.35(%)
  • Bharat Dynamics
    2,096.00 2,096.00(%)
  • Engineers India
    239.00 304.00(%)
  • NBCC
    126.41 139.83(%)
  • IFCI
    66.71 35.67(%)
  • Muthoot Finance
    2,241.75 2,444.65(%)
  • HDFC Bank
    1,948.60 1,977.95(%)
  • LMW
    16,640.85 13,456.85(%)
  • Hind.Aeronautics
    4,962.00 3,045.95(%)
  • Pidilite Inds.
    3,127.25 3,414.40(%)
  • Infosys
    1,555.10 1,307.10(%)
  • Ola Electric
    48.07 45.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Brooks Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 40505.0
  • ISIN : INE650L01011
143.33 7 (5.00%)
  • As on 31 May 2025 (EOD)

  • Today’s Low

    143.33

  • Today’s High

    143.33

  • Open

    143.33

  • Perv Close

    136.51

  • 52W Low

    73.25

  • 52W High

    198.86

Key Indicators

  • P/E(TTM)

    137.93

  • Mar.Cap (₹Cr.)

    422.21

  • Div & Yield %

    0.00

  • Book Value(₹)

    39.06

  • Debt-Equity Ratio

    5.00

  • AGM Date

    30-May-2025

  • EPS

    1.04

  • P/E Ratio

    137.93

Financials Ratios

  • Debt-Equity Ratio

    0.09

  • Mar.Cap (₹Cr.)

    422.21

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    29.46

  • BV (₹)

    39.10

  • Sales( ₹ in Cr.)

    82.56

  • NP (in Cr.)

    3.05

  • NP Var(%)

    101.0

  • Div%

    0.0

  • CPS (₹)

    1.60

  • EPS (₹)

    1.00

  • Traded Value (₹ in Lakhs)

    422.56

  • 52 Week High

    198.86

  • 52 Week Low

    73.25

  • Price BSE

    143.0

  • Price NSE

    143.00

  • Market Capital( in Cr.)

    422.56

  • P/C Ratio

    90.50

  • P/E Ratio

    138.00

  • Price Vs.BV

    1.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 79.49 55.54 76.97 77.27 69.69 55.03
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 79.49 55.54 76.97 77.27 69.69 55.03
Other Income 0.96 0.12 0.95 0.96 0.41 2.88
Stock Adjustments -1.40 -2.01 2.93 3.34 3.29 1.14
Total Income 79.05 53.65 80.85 81.57 73.39 59.05
EXPENDITURE :            
Raw Materials 56.59 39.48 53.59 52.56 50.13 40.57
Power and Fuel Cost 1.73 1.58 1.64 2.70 2.90 2.56
Employee Cost 10.09 10.65 10.88 12.04 11.16 10.04
Other Manufacturing Expenses 1.34 1.22 3.77 3.17 3.75 3.45
Selling and Administration Expenses 4.05 4.91 6.39 6.57 5.88 4.86
Miscellaneous Expenses 1.07 1.50 1.75 2.63 3.08 3.05
Employee Benefit Expenses 10.09 10.65 10.88 12.04 11.16 10.04
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 74.87 59.34 78.02 79.67 76.90 64.53
Operating Profit 4.17 -5.70 2.82 1.91 -3.52 -5.49
Interest 0.84 0.77 0.67 3.25 3.35 2.96
Gross Profit 3.33 -6.47 2.15 -1.34 -6.87 -8.45
Depreciation 1.77 1.72 1.49 7.09 6.65 6.50
Profit Before Tax 1.56 -8.19 0.66 -8.43 -13.52 -14.95
Current Tax 0.03 0.00 0.00 7.15 9.12 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 1.74 -0.14
Reported Net Profit 1.53 -8.18 0.67 -15.59 -24.38 -14.81
Extraordinary Items 0.01 0.01 0.26 -0.06 -1.18 0.17
Adjusted Net Profit 1.52 -8.19 0.41 -15.53 -23.20 -14.98
Adjustment below Net Profit 0.00 0.00 0.00 -18.73 -0.05 0.00
P & L Balance brought forward -36.30 -28.12 -28.79 5.53 29.96 44.76
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -34.78 -36.30 -28.12 -28.79 5.53 29.96
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.58 -3.31 0.27 -6.31 -9.87 0.00
Earnings Per Share(Adj)-Unit Curr 0.58 -3.28 0.27 -6.25 -9.77 0.00
Book Value 26.49 22.98 26.31 25.99 39.84 64.96
Book Value(Adj)-Unit Curr 26.49 22.76 26.06 25.74 39.45 53.64

Shareholding Pattern

  • Promoter Group

    52.62%

  • Public Share Holding

    47.38%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 15,500,292 52.62 15,500,292 8
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 15,500,292 52.62 15,500,292 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 15,980 0.05 15,980 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 2,916,111 9.90 2,916,111 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 141,340 0.48 141,340 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 3,073,431 10.43 3,073,431 4
2] Non Institution
Bodies Corporate 1,025,076 3.48 1,025,076 68
Clearing Members 4,460 0.02 4,460 2
Directors of their Relatives 100 0.00 100 1
Employees 1,865 0.01 537 7
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 190,092 0.65 190,092 134
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 276,080 0.94 276,080 232
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 4,071,889 13.82 4,071,889 62
Individuals holding nominal share capital up to Rs. 1 lakh 5,313,963 18.04 5,313,591 10,019
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 10,883,525 36.95 10,881,825 10,525
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 29,457,248 100.00 29,455,548 10,537

Company Background

Brooks Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Brooks Laboratories Ltd
  • BSE Code : 40505.0
  • ISIN : INE650L01011

  • Incorporation Year

    2002

  • Registered Office

    Village Kishanpura
    Nilagarh Road Baddi, Solan,
    Himachal Pradesh-174101

  • Telephone

    91-1795-654001/02/03

  • FAX

    91-1795-236939

  • Chairman

  • Managing Director

  • Company Secretary

  • Auditor

    DMKH & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Brooks Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Brooks Lab. 143.45 80.44 79.49 137.93 2.72
Abbott India 30,453.15 6,097.18 5,848.91 45.75 44.71
Astrazeneca Phar 7,965.20 1,330.33 1,295.53 205.34 33.26
P & G Health Ltd 5,775.85 1,166.89 1,151.26 40.53 39.76
Glaxosmi. Pharma 3,295.00 3,530.73 3,407.25 60.74 44.44
Cipla 1,464.85 17,645.00 16,574.34 22.94 20.10
Amrutanjan Healt 711.95 437.58 421.23 40.50 20.84
Fermenta Biotec. 311.95 315.24 307.09 13.58 4.10
Guj. Themis Bio. 307.95 174.19 169.82 68.74 44.82
Bliss GVS Pharma 131.10 638.96 605.46 20.02 11.19
Ambalal Sarabhai 37.87 11.70 3.81 16.18 1.92